gel-e, Inc

10 articles about gel-e, Inc

• Continued Expansion of gel-e's Consumer Products Label

  10/31/2019

  Unique product platform combines antibacterial capabilities within a high-performance hemostat

• Breakthrough Device Designation received from the FDA

  6/18/2019

  Accelerated regulatory pathway for first internal use product

• Successful First Use of gel-e in a Surgical Model

  4/3/2019

  Demonstrating safety and efficacy in a high-dose treatment of a first flowable formulation

• gel-e Expands Patent Estate with Next Level of Exclusivity

  1/21/2019

  Issuance of broad technology claims protects clinical, surgical and consumer medical devices and their use

• gel-e expands its OTC label

  6/29/2018

  US FDA clearance of the Company's first flowable product paves the way for the next-generation of high-performance First Aid

• gel-e Expands Clinical Advisory Board With More Surgical Talent

  1/10/2018

  gel-e announces the expansion of its Clinical Advisory Board to include Dr. Grant Bochicchio, Chief of Acute and Critical Care Surgery at Washington University School of Medicine.

• gel-e Expands Board of Directors With Domain & Commercial Strategy Expert

  12/22/2017

  gel-e, a privately held, clinical-stage medical device company, announces the expansion of its Board of Directors to include industry veteran Jim Buck.

• 

  gel-e Wins FDA OK to Expand its Bandage Product Line for Rx and OTC Use

  12/14/2017

  gel-e announces the 510(k) clearance of its adhesive bandage by the FDA for prescription and OTC use.

• gel-e, Inc Expands Core Team With Regulatory, Manufacturing And Financial Talent

  9/13/2017

• gel-e, Inc Secures $3.1 Million Financing For Innovative Hemostatic And Advanced Wound Treatment Platform

  7/13/2017